![Brian Cain](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ursprung des Netzwerks ersten Grades von Brian Cain
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Iqure Pharma, Inc.
![]() Iqure Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Iqure Pharma, Inc. is a biotech company that develops therapeutics for patients and physicians. The company is based in Wilmington, DE. The company was founded by Pawel Zolnierczyk, Henk de Wilde, Peter Schiemann, Anna Rzewuska. Pawel Zolnierczyk has been the CEO since incorporation.
6
| Holding Company | Miscellaneous Commercial Services | 6 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Brian Cain
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Anchor Therapeutics, Inc.
![]() Anchor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Anchor Therapeutics, Inc. designs and develops peptide modulators of G protein-coupled receptors (GPCRs). The firm engages in developing and licensing pepducin technology as a research tool for drug development; and pepducin drug candidates and novel molecules that are intended for targeting GPCR to allosterically modulate GPCR signaling. Its pepducin lipopeptides are designed to allosterically modulate internal cell signaling via specific interactions with intracellular GPCR domains. The company also focuses on developing its pepducin technology for creating new treatment options for regenerative medicine, diabetes, inflammation, and cancer. Anchor Therapeutics was founded by Thomas J. McMurry and Athan Kuliopulos in 2006 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Founder | |
Allegro Diagnostics Corp.
![]() Allegro Diagnostics Corp. Medical/Nursing ServicesHealth Services Allegro Diagnostics Corp. develops and commercializes molecular diagnostics system. It focuses on lung cancer and other pulmonary diseases using proprietary gene expression technology originating within the Pulmonary Center at the Boston University School of Medicine. The company was founded by Jerome S. Brody and Avrum Spira on April 20, 2007 and is headquartered in Maynard, MA. | Medical/Nursing Services | President | |
University of Salford | College/University | Corporate Officer/Principal | |
University of Kansas | College/University | Undergraduate Degree | |
University of Sussex | College/University | Graduate Degree | |
CEO Roundtable on Cancer, Inc.
![]() CEO Roundtable on Cancer, Inc. Miscellaneous Commercial ServicesCommercial Services CEO Roundtable on Cancer, Inc. promotes activities to reduce cancer risk, enable early detection, facilitate better access to treatment and hasten the discovery. Its programs include CEO cancer gold standard, life sciences consortium and project data sphere. The company was founded by George H. W. Bush in 2001 and is headquartered in Durham, NC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Massachusetts Biotechnology Council
![]() Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell. | Miscellaneous Commercial Services | Chairman | |
Tyrogenex, Inc.
![]() Tyrogenex, Inc. Pharmaceuticals: MajorHealth Technology Tyrogenex, Inc. operates as a biopharmaceutical company which develops dual vascular endothelial growth factor receptor and platelet-derived growth factor receptor inhibitors for wet age-related macular degeneration and solid tumors. Its compound targets the basic mechanisms of neovascular eye diseases, including angiogenesis, fibrosis and inflammation. The company was founded by Chris Liang, Teri Ardleigh Swift, and Sheridan G. Snyder and is headquartered in Rockville, MD. | Pharmaceuticals: Major | Director/Board Member | |
Incanthera Oncology Ltd.
![]() Incanthera Oncology Ltd. Medical DistributorsDistribution Services Incanthera Oncology Ltd. engages in the provision of drug development services. The company was founded on April 7, 2011 and is headquartered in Manchester, the United kingdom. | Medical Distributors | Director/Board Member | |
Kellogg School of Management | College/University | Masters Business Admin | |
Incanthera Research & Development Ltd.
![]() Incanthera Research & Development Ltd. Medical DistributorsDistribution Services Incanthera Research & Development Ltd. develops drug delivery solutions for solid tumor chemotherapy. It offers cancer therapies, such as ICT01-2588, a vascular disrupting agent and drug delivery platform for lung and prostate cancer; and ICT03-Es5, a bioreductive anticancer agent for lung, liver, and breast cancer. The company was founded by Alan McGowan, Paul Loadman, Laurence Patterson, Andrew John Michael Duley, John Anthony Hadfield, Robert Falconer, and Jason Gill in 2010 and is headquartered in Manchester, the United Kingdom. | Medical Distributors | Chief Operating Officer | |
Deuterx LLC
![]() Deuterx LLC Miscellaneous Commercial ServicesCommercial Services Deuterx LLC engages in research of biotechnology. It also engages in development of biotechnology. The company was founded by Anthony W. Czarnik in 2012 and is headquartered in Andover, MA. | Miscellaneous Commercial Services | Director/Board Member | |
Incanthera Plc
![]() Incanthera Plc Pharmaceuticals: MajorHealth Technology Incanthera Plc operates as a holding company, which focuses on drug discovery and development of targeted medicines for the treatment of cancer. The firm products include Sol, EP0015, Equin & Duo-C. The company was founded on March 2, 2010 and is headquartered in Manchester, the United Kingdom. | Pharmaceuticals: Major | Chief Operating Officer | |
ENVERIC BIOSCIENCES, INC. | Pharmaceuticals: Other | Chairman | |
CXL Ophthalmics LLC
![]() CXL Ophthalmics LLC Medical/Nursing ServicesHealth Services CXL Ophthalmics LLC develops a treatment for eyecare. The company is based in Encinitas, CA. The CEO of the company is Michael D. Webb. | Medical/Nursing Services | Chief Executive Officer | |
Ymmunobio AG
![]() Ymmunobio AG BiotechnologyHealth Technology Ymmunobio AG is a Swiss preclinical stage oncology biotech company that develops innovative treatments for cancer patients through new classes of antibodies. The company is based in Riehen, Switzerland. The company focuses on high unmet need indications in gastro-intestinal cancers, making extensive progress in developing first-in-class or novel class of antibodies that have the potential to overcome resistance of cancer patients to current available therapies. Ymmunobio's research is based on their deep understanding of immuno-oncology and precision cancer treatments, leveraging their profound knowledge of biologics while selecting the optimal approach to developing transformative therapeutics across cancer indications. The company was founded in 2021 by Katrin Rupalla. The CEO is Peter Schiemann. | Biotechnology | Chief Executive Officer | |
Politechnika Gdanska | College/University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 13 |
Vereinigtes Königreich | 6 |
Schweiz | 2 |
Polen | 2 |
Sektoral
Health Technology | 8 |
Consumer Services | 6 |
Commercial Services | 4 |
Health Services | 3 |
Distribution Services | 3 |
Operativ
Director/Board Member | 10 |
Founder | 6 |
President | 5 |
Chairman | 5 |
Chief Executive Officer | 4 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Michael Webb | 17 |
Pawel Zolnierczyk | 6 |
Peter Schiemann | 2 |
Henk de Wilde | 1 |
Anna Rzewuska | 1 |
Mike Webb | 1 |
- Börse
- Insiders
- Brian Cain
- Unternehmensverbindungen